Sign In
Buy WGS
$53.02
-0.110 (-0.207%)
At Close: Jun 03, 2026
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Co
WGS Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 Sales View
10:51am, Tuesday, 29'th Jul 2025
GeneDx reports strong Q2 results with record revenues and surging profits. A raised 2025 sales outlook fuels a 26% stock jump.
GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Beat Estimates
08:41am, Tuesday, 29'th Jul 2025
GeneDx Holdings Corp. (WGS) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to a loss of $0.11 per share a year ago.
GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights
06:30am, Tuesday, 29'th Jul 2025
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS) today reported its financial results for the second quarter of 2025.
Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
06:34pm, Monday, 28'th Jul 2025
NEW YORK , July 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Corp.
Why GENEDX HOLDINGS (WGS) Could Beat Earnings Estimates Again
01:10pm, Monday, 28'th Jul 2025
GENEDX HOLDINGS (WGS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group
10:42am, Monday, 28'th Jul 2025
LOS ANGELES , July 28, 2025 /PRNewswire/ -- News provided by DJS Law Group LLP The DJS Law Group reminds investors that it is investigating claims GeneDx Holdings Corp. ("GeneDx" or "the Company") (N
Will Exome and Genome Growth Boost WGS' Q2 Earnings?
10:31am, Monday, 28'th Jul 2025
GeneDx is likely to have experienced a Q2 lift, backed by strong Exome and genome test volumes, new indications and strategic tech moves.
WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm
09:43am, Monday, 28'th Jul 2025
LOS ANGELES , July 28, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of GeneDx Holdings Co
ROSEN, A LEADING LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation – WGS
01:00pm, Saturday, 26'th Jul 2025
NEW YORK, July 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Co
GeneDx CFO Sells More Than Half of His Shares
02:40pm, Friday, 25'th Jul 2025
On July 11, 2025, Kevin Feeley, Chief Financial Officer of GeneDx Holdings (WGS -2.00%), reported the sale of 5,278 shares of the company in multiple transactions, reducing his post-transaction holdin
NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Co
GeneDx Holdings Corp. (WGS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:07am, Tuesday, 22'nd Jul 2025
GENEDX HOLDINGS (WGS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group
05:28am, Tuesday, 22'nd Jul 2025
LOS ANGELES , July 22, 2025 /PRNewswire/ -- The DJS Law Group reminds investors that it is investigating claims GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) for violations of secu
Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
02:46pm, Monday, 21'st Jul 2025
NEW YORK , July 21, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Corp.
